Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Integration of Immuno-Oncology into Contemporary Management of Muscle-invasive Urothelial Carcinoma
June 2024
At the European Association of Urology (EAU) 2024 Conference, Jürgen Gschwend (Department of Urology, Hopital Rechts der Isar Technical…
Read more
20th March 2015
ESMO 2014: The collaboration between basic scientists and clinicians
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, UK) discusses how the increased interaction between basic scientists, clinicians…
20th March 2015
ESMO 2014: The TRACERx study of lung cancer
At ESMO 2014 Congress, Prof Charles Swanton (London Research Institute and UCL, UK) discusses TRAcking Cancer Evolution through therapy (TRACERx), which…
20th March 2015
ESMO 2014: Tumour evolution and precision medicine
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution…
20th March 2015
ESMO 2014: Tumour evolution and proactive clinical management
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how we can begin to anticipate tumour evolutionary…
16th March 2015
ESMO 2014: The collaboration between UCL and the Francis Crick Institute
At ESMO 2014, Prof Jonathan Ledermann (UCL, UK) discusses the collaboration between UCL and the Francis Crick Institute that is hoped to increase the…
16th March 2015
ESMO 2014: Inhibition of PARP, angiogenesis and immune checkpoints for ovarian cancer management
At ESMO 2014, Prof Jonathan Ledermann (University College London, UK) provides an update on the management of ovarian cancer, including maintenance…
17th February 2015
ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
Dr Andrew Davies (University of Southampton, Southampton, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses a phase II/III…
12th February 2015
The role of nurses for supporting patients with myeloma
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Monica Morris, Healthcare Professional Programme Manager, Myeloma UK…
Loading posts...
« Previous
1
…
43
44
45
46
Next »